GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Emcure Pharmaceuticals EMCURE.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

2,216.20

+0.15%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Emcure Pharmaceuticals

Our reporting

Next results

11 Feb 2027

Due on 11 Feb 2027. on revenue of ₹27.15bn.

Past results

Reported against what analysts expected

3 Nov 20266 Aug 20265 May 20264 Feb 202611 Nov 20257 Aug 2025
Earnings per share17.1615.4014.1012.4012.8011.10
Forecast0.1612.6013.6010.8012.009.90
Revenue₹28.20bn₹25.80bn₹24.70bn₹23.64bn₹22.70bn₹21.00bn
Forecast₹26.65bn₹23.99bn₹24.11bn₹22.55bn₹22.38bn₹20.54bn

Key events

  1. 10 Jul 2024Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.